, 2011, Van Riel et al., 2010, Welkenhuysen and Evers-Kiebooms, 2002, White et al., 2008, Wideroff et al., 2003, Wideroff et al., 2005 and Wilkins-Haug Selleck BIBF-1120 et al., 2000). Many physicians do not have any specific education and the vast majority does not feel they have the needed training and knowledge for the appropriate

use of genetic testing to guide prevention or treatment decisions (Anon, 2011 and Feero and Green, 2011). Recent surveys tested the effectiveness of educational interventions at improving the competency of doctors in this field (Bethea et al., 2008, Carroll et al., 2008, Carroll et al., 2009 and Drury et al., 2007). The present study assessed the knowledge, attitudes, and professional behavior of a random sample of Italian physicians toward the use of predictive genetic testing for breast and colorectal cancer, particularly the BRCA 1/2 and APC tests. A variety of determinants were explored, including education. In 2010, a self-administered anonymous questionnaire was e-mailed to 1670 physicians randomly selected from the registers of the Board of Physicians of Provinces of Rome and Florence. The physicians were chosen irrespective of their specialty because this information is not recorded

in the registers. The online questionnaire could only be answered once. Second and third questionnaires were e-mailed to non-responders 3 and 6 months after the initial e-mail. To maximize the response rate, telephone calls were placed before each of the follow-up mailings. A total of 107 physicians could not be contacted by telephone because their numbers were not MLN0128 order available. The questionnaire (a copy is available upon request) comprised a series of questions designed to assess the following: i) the physicians’ demographics and personal and professional Cell press characteristics; ii) their knowledge, attitudes, and professional use of genetic tests for breast and colorectal cancer; iii) their self-estimated level of knowledge and training needs. Knowledge about predictive genetic tests for cancer was investigated

through six questions using a three-point options Likert scale (“agree”, “uncertain,” and “disagree”) [see Table 2(A) for the actual items used]. Additional four multiple-choice questions were designed to evaluate the physicians’ knowledge concerning the prevalence of hereditary breast cancer and inherited forms of colorectal cancer and the penetrance of BRCA1/BRCA2 and APC mutations [see Table 2(B)]. A Likert three-point scale was used to assess the physicians’ attitudes through seven questions (see Table 4). In the behavior section, physicians were asked if they had administered genetic tests for breast and colorectal cancer to their patients during the previous 2 years and queried about the importance of genetic counseling and collecting information about the family and personal history of cancer.